Ms. Shweta Mehta, a member of the Promoter Group of Medico Remedies Limited, has disclosed the sale of 9,00,000 equity shares.

This transaction is part of the company's compliance with SEBI regulations concerning insider trading.

The sale's implications for stock performance and potential shifts in shareholder composition warrant close observation.

Stakeholders should consider the potential market impact due to this significant share movement, especially in light of any forthcoming developments in the company's operational strategy.